Skip to main content

Find Clinical Trials

Home
Conditions
Glycogen Storage Disease Type II

Clinical trial condition

Glycogen Storage Disease Type II

Explore clinical trials studying Glycogen Storage Disease Type II. Study availability and eligibility vary by location and protocol.

108 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Glycogen Storage Disease Type II trial results

Not yet recruiting

A Study of S-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD)

NCT07787650

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD)

NCT07750990

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

Treatment Frequency Reduction in Pompe Disease

NCT06575829

Conditions: Acid Maltase Deficiency, Brain Diseases, Brain Diseases, Metabolic, +15 more
Locations: Not specified

View Trial Details

Not yet recruiting

Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)

NCT06178432

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations: Huashan Hospital of Fudan University Shanghai, China

View Trial Details

Not yet recruiting

Higher Dose of Alglucosidase Alpha for Pompe Disease

NCT05017402

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

NCT06605612

Conditions: Amyotrophic Lateral Sclerosis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +67 more
Locations: Friedrich-Baur-Institut, Neurologische Klinik und Poliklinik, LMU Klinikum, Ludwig-Maximilians-Universität München München, Bavaria, Germany

View Trial Details

Enrolling by invitation

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

NCT07072676

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +69 more
Locations: Medical Park, Bad Feilnbach, Reithofpark Bad Feilnbach, Germany

View Trial Details

Active, not recruiting

A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease

NCT06150820

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations: Emory Clinic Atlanta, Georgia, United States

University of Kansas Medical Center Kansas City, Kansas, United States

University of Michigan Ann Arbor, Michigan, United States

Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States

View all 53 locations

View Trial Details

Active, not recruiting

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

NCT03911505

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations: University of Florida Clinical Research Center Gainesville, Florida, United States

Wolfson Children's Hospital Jacksonville, Florida, United States

Woodruff Memorial Research Building Atlanta, Georgia, United States

St. Louis Children's Hospital St Louis, Missouri, United States

View all 17 locations

View Trial Details

Active, not recruiting

Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)

NCT05164055

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
Locations: Investigational Site Number : 2500004 Bordeaux, France

Investigational Site Number : 2500005 Brest, France

Investigational Site Number : 2500008 Clermont-Ferrand, France

Investigational Site Number : 2500009 Lille, France

View Trial Details